英アストラゼネカ、日本政府と最終合意　１億２０００万回分ワクチン供給

　【ロンドン時事】英製薬大手アストラゼネカの日本法人は１１日、新型コロナウイルスのワクチンを１億２０００万回分供給することで日本政府と最終合意したと発表した。日本で実施している臨床試験（治験）の結果も踏まえ、日本の規制当局に承認を申請する考えを示した。
　アストラゼネカは英国などでの治験の結果、平均７０％、最高９０％の確率で効果を示したと発表している。既に英国などでは承認申請済みだが、日本での承認は欧米に比べて遅れる見通しだ。（2020/12/12-11:05）

AstraZeneca PLC said Friday that it has reached a final agreement with the Japanese government to provide the country with its coronavirus vaccine.
   The British pharmaceutical company will provide Japan with 120 million doses of the vaccine, enough to inoculate 60 million people, roughly half of the country's population.
   AstraZeneca said it will file for regulatory approval of the vaccine in Japan, based on results of clinical trials, including one in the country.
   The company has said that the vaccine was found be up to 90 pct and an average of 70 pct effective. It has already applied for approval in countries including Britain.
   The two-shot vaccine can be stored at 2-8 degrees Celsius, significantly higher than minus 70 degrees required for rival vaccines.